New Drug Linked With Reduced Hearing Loss in Kids Post Chemo

Administering the antioxidantsodium thiosulfate (STS) to cisplatin-treated children cut their risk of hearing loss by almost 50 percent in research published in the New England Journal of Medicine.

Source: The ASHA Leader Online - August 31, 2018 Category: Speech-Language Pathology Source Type: research